A61K 31/4178
Not condensed 1,3-diazoles and containing further heterocyclic rings
Official title: not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K31/4178 (Not condensed 1,3-diazoles and containing further heterocyclic rings) appears on 1,766 US grants and 3,192 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,766
- Published applications
- 3,192
- Assignees
- 1,269
- Inventors
- 6,374
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 7 | 0 |
| 1991 | 1 | 0 |
| 1992 | 12 | 0 |
| 1993 | 11 | 0 |
| 1994 | 11 | 0 |
| 1995 | 9 | 0 |
| 1996 | 16 | 0 |
| 1997 | 24 | 0 |
| 1998 | 28 | 0 |
| 1999 | 26 | 0 |
| 2000 | 22 | 0 |
| 2001 | 21 | 7 |
| 2002 | 28 | 41 |
| 2003 | 25 | 55 |
| 2004 | 14 | 85 |
| 2005 | 15 | 88 |
| 2006 | 27 | 70 |
| 2007 | 15 | 78 |
| 2008 | 27 | 71 |
| 2009 | 18 | 80 |
| 2010 | 26 | 95 |
| 2011 | 30 | 115 |
| 2012 | 45 | 126 |
| 2013 | 70 | 133 |
| 2014 | 108 | 197 |
| 2015 | 112 | 166 |
| 2016 | 113 | 204 |
| 2017 | 137 | 191 |
| 2018 | 127 | 166 |
| 2019 | 125 | 163 |
| 2020 | 111 | 171 |
| 2021 | 82 | 156 |
| 2022 | 80 | 152 |
| 2023 | 58 | 153 |
| 2024 | 73 | 167 |
| 2025 | 63 | 141 |
| 2026 | 42 | 121 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Losartan-containing micro tablet for pediatric applications15 Sep 2026US 12,734,131 B2Midas Pharma GmbH
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Methods of treating inflammation8 Sep 2026US 12,728,114 B2Veru Inc.
- Daclatasvir for use in treating lung and prostate cancer1 Sep 2026US 12,721,838 B2Henry Ford Health System
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- Plasmin-induced internal limiting membrane digestion facilitates donor retinal ganglion cell transplantation8 Oct 2026US 2026/0306549 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Uric acid transporter agonist compound, pharmaceutical composition, and preparation method therefor and use thereof8 Oct 2026US 2026/0308136 A1Hangzhou E & J Biopharmaceutical Technology Co., Ltd.
- Ketamine for the treatment of menstrually related symptoms1 Oct 2026US 2026/0294843 A1
- Compositions for the treatment of hypertension24 Sep 2026US 2026/0284022 A1The George Institute for Global Health
Most cited
By later US patents
- Sustained release, comfort formulation for glaucoma therapy329US 4,911,920 AAlcon Laboratories, Inc. · 1990
- Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces174US 5,800,832 AVirotex Corporation · 1998
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces116US 7,579,019 B2Arius Two, Inc. · 2009
- Controlled release of pharmaceuticals in the anterior chamber of the eye111US 5,972,326 A1999